Chen C K, Su H H, Sun I W
Department of Psychiatry, Tri-Service General Hospital, Taipei, Taiwan.
Department of Psychiatry, MacKay Memorial Hospital, Hsinchu, Taiwan.
East Asian Arch Psychiatry. 2017 Sep;27(3):91-6.
This survey aimed to understand the attitude of psychiatrists and their use of commonly prescribed second-generation antipsychotics (SGAs) for the treatment of schizophrenia in Taiwan. It also attempted to identify the factors that might influence their preference for selecting SGAs.
Psychiatrists were interviewed face-to-face using a structured questionnaire. The questionnaire addressed various issues involved in the treatment of patients with schizophrenia, including the reasons for selecting SGAs, psychiatrists' level of satisfaction with commonly prescribed SGAs, and their current use of SGAs in clinical practice.
Gender and age of the psychiatrists, and practice setting were not related to SGA selection. The selection of a SGA might be influenced by characteristics of the psychiatrist, properties of the drugs, and the healthcare insurance system. Most psychiatrists agreed that the performance of brand-name drugs was superior to that of generic drugs. Better symptom control, improvement in cognition, and higher tolerability were among the major factors considered by psychiatrists in Taiwan when prescribing antipsychotics.
Selection of a SGA in Taiwan is potentially influenced by the characteristics of the psychiatrist, properties of the drug, and the healthcare insurance system. Efficacy and tolerability were among the major determining factors when prescribing antipsychotics for the treatment of patients with schizophrenia.
本调查旨在了解台湾精神科医生对治疗精神分裂症常用第二代抗精神病药物（SGA）的态度及其使用情况。同时试图确定可能影响他们选择SGA偏好的因素。
采用结构化问卷对精神科医生进行面对面访谈。问卷涉及精神分裂症患者治疗中的各种问题，包括选择SGA的原因、精神科医生对常用SGA的满意度以及他们目前在临床实践中使用SGA的情况。
精神科医生的性别、年龄以及执业环境与SGA的选择无关。SGA的选择可能受精神科医生的特征、药物特性和医疗保险系统的影响。大多数精神科医生认为品牌药的性能优于仿制药。症状控制更好、认知改善以及耐受性更高是台湾精神科医生在开抗精神病药物时考虑的主要因素。
在台湾，SGA的选择可能受到精神科医生的特征、药物特性和医疗保险系统的影响。疗效和耐受性是为精神分裂症患者开抗精神病药物时的主要决定因素。
